COMMUNIQUÉS West-GlobeNewswire
 
      -   
  SoldierStrong and Iowa State Fraternal Order of Eagles Donate Robotic Exoskeleton to Younker Rehabilitation26/07/2018
-   
  Dermatology Experts Present Latest Information at 2018 AAD Summer Meeting; American Academy of Dermatology26/07/2018
-   
  The Joint Corp. to Host Conference Call on Thursday, August 9, to Discuss Second Quarter 2018 Results26/07/2018
-   
  Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 201826/07/2018
-   
  Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New DischargeRx Program26/07/2018
-   
  Spine Injury Solutions Inc. (SPIN) Expands Its Affiliate Spine Diagnostic Practices To Include Concussion/Traumatic Brain Injury (TBI) Testing26/07/2018
-   
  aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference26/07/2018
-   
  Extendicare Announces Pending Departure of CEO26/07/2018
-   
  Tetra Bio-Pharma Confirms Meetings With FDA26/07/2018
-   
  Kalytera Therapeutics Announces Filing of Amended and Restated Short Form Prospectus26/07/2018
-   
  ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission26/07/2018
-   
  Inovalon Achieves Significant Advancement in Cloud Computing Capabilities26/07/2018
-   
  Otonomy Initiates Phase 3 Clinical Trial of OTIVIDEX™ in Ménière’s Disease26/07/2018
-   
  Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated26/07/2018
-   
  Emblem Corp. Signs Letter of Intent to Acquire Natura Naturals26/07/2018
-   
  Pain Therapeutics Reports Second Quarter 2018 Financial Results26/07/2018
-   
  Asterias Biotherapeutics to Report Second Quarter 2018 Results on August 9, 201826/07/2018
-   
  Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints26/07/2018
-   
  Aclaris Therapeutics to Announce Second Quarter 2018 Financial Results on August 3, 201826/07/2018
Pages